NIS-LL: The Primary Measurement Scale for Clinical Trial Endpoints in Diabetic Peripheral Neuropathy

Publisher： Karger

E-ISSN： 1421-9913|41|1|8-13

ISSN： 0014-3022

Source： European Neurology, Vol.41, Iss.1, 1999-02, pp. : 8-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Diagnosis and Management of Diabetic Peripheral Neuropathy

By  

European Neurology, Vol. 41, Iss. 1, 1999-02 ,pp. : 3-7

Karger

Access to resources Recommend Favorite

Neurotrophic Factors and Diabetic Peripheral Neuropathy

By  

European Neurology, Vol. 41, Iss. 1, 1999-02 ,pp. : 27-34

Karger

Access to resources Recommend Favorite

The Diagnostic Value of Neuropathy Symptom and Change Score, Neuropathy Impairment Score and Michigan Neuropathy Screening Instrument for Diabetic Peripheral Neuropathy

By  

European Neurology, Vol. 74, Iss. 5-6, 2015-0 ,pp. : 323-327

Karger

Access to resources Recommend Favorite

Clinical Potential of Aldose Reductase Inhibitors in Diabetic Neuropathy

By Hamada Yoji   Nakamura Jiro  

Treatments in Endocrinology, Vol. 3, Iss. 4, 2004-01 ,pp. : 245-255

Adis International

Access to resources Recommend Favorite

Emerging Therapies for Diabetic Neuropathy: A Clinical Overview

By  

Current Diabetes Reviews, Vol. 1, Iss. 3, 2005-11 ,pp. : 271-280

Bentham Science Publishers

Access to resources Recommend Favorite